BRIEF-Iterum Therapeutics Says FDA Needs More Time To Review Materials Provided In Support Of NDA
Reuters2021-04-09
April 9 (Reuters) - Iterum Therapeutics PLC :
* ITERUM THERAPEUTICS - GOT NOTICE FROM FDA THAT FDA NEEDS MORE TIME TO REVIEW MATERIALS PROVIDED IN SUPPORT OF NDA FOR SULOPENEM ETZADROXIL/PROBENECID
* ITERUM THERAPEUTICS PLC - PREVIOUSLY SCHEDULED FDA ANTIMICROBIAL DRUGS ADVISORY COMMITTEE ON JUNE 2, 2021 HAS BEEN POSTPONED
* ITERUM THERAPEUTICS PLC - NEW DATE FOR FDA PANEL REVIEW OF COMPANY'S NDA HAS NOT YET BEEN CONFIRMED
* ITERUM THERAPEUTICS PLC - CONTINUES TO WORK CLOSELY WITH FDA TO FACILITATE ITS PANEL REVIEW
Source text for Eikon: [ Further company coverage:
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
